First Horizon Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.81 Billion
- Q2 2025
A detailed history of First Horizon Advisors, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 15,417 shares of REGN stock, worth $10.4 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
15,417
Previous 15,314
0.67%
Holding current value
$10.4 Million
Previous $9.71 Million
16.67%
% of portfolio
0.21%
Previous 0.28%
Shares
32 transactions
Others Institutions Holding REGN
# of Institutions
1,458Shares Held
87.1MCall Options Held
1.77MPut Options Held
1.74M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.1 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.7 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.26 Billion0.1% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.75 Billion0.15% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.58 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...